`
`United States Court of Appeals
`FOR THE
`SECOND CIRCUIT
`_________________
`
`At a stated term of the United States Court of Appeals for the Second
`Circuit, held at the Thurgood Marshall United States Courthouse, 40 Foley Square,
`in the City of New York, on the 7th day of August, two thousand twenty-three.
`
`Present:
`
`Jon O. Newman,
`Richard C. Wesley,
`Eunice C. Lee,
`Circuit Judges.
`
`In Re: Purdue Pharma L.P., Purdue Pharma Inc, Purdue
`Transdermal Technologies L.P.,
`Purdue
`Pharma
`Manufacturing L.P., Purdue Pharmaceuticals L.P., Imbrium
`Therapeutics L.P., Adlon Therapeutics L.P., Greenfield
`BioVentures L.P., Seven Seas Hill Corp., Ophir Green
`Corp., Purdue Pharma of Puerto Rico, Avrio Health L.P.,
`Purdue Pharmaceutical Products L.P., Purdue Neuroscience
`Company, Nayatt Cove Lifescience Inc., Button Land L.P.,
`Rhodes Associates L.P., Paul Land Inc., Quidnick Land L.P.,
`Rhodes Pharmaceuticals L.P., Rhodes Technologies, UDF
`LP, SVC Pharma LP, SVC Pharma Inc.,
` Debtors.
`
`ORDER
`
`Docket Nos. 22-110-bk(L),
`22-113-bk(Con), 22-115-bk(Con),
`22-116-bk(Con), 22-117-bk(Con),
`22-119-bk(Con), 22-121-bk(Con),
`22-299-bk(Con), 22-203-bk(XAP)
`
`On July 29, 2024, the Supreme Court issued a certified copy of its judgment in this case. See Dkt.
`1059 (certified judgment); S. Ct. R. 45(3) (governing mandates issued by the high Court). That
`judgment reversed this Court’s previous judgment, 69 F.4th 45 (2d Cir. 2023), and remanded the
`case for further proceedings consistent with the Supreme Court’s June 27, 2024 opinion, 144 S.
`Ct. 2071 (2024).
`
`IT IS HEREBY ORDERED that this case is remanded to the district court for further proceedings
`consistent with the Supreme Court’s decision.
`
`FOR THE COURT:
`Catherine O’Hagan Wolfe, Clerk of Court
`
`